Still more questions than answers: Report on the 5th International Symposium on Insulin-like Growth Factors, Brighton, UK, 31 October - 4 November 1999

Trends in Endocrinology and Metabolism

Volumn 11, Issue 4, 2000, Pages 151-153

  Holly, Jeff M P ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR;

BODY GROWTH; CANCER; CONFERENCE PAPER; GENE DELETION; GENE EXPRESSION REGULATION; HORMONE ACTION; KNOCKOUT GENE; PRIORITY JOURNAL;

GROWTH; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS; SOMATOMEDINS;

EID: 0034090876     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(00)00239-3     Document Type: Conference Paper

References (5)

1. Yakar S.et al. Normal growth and development in the absence of hepatic insulin-like growth factor-I. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7324-7329.
2. Sjogren K.et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7088-7092.
3. Chan J.M.et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 279:1998;563-566.
4. Hankinson S.E.et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 351:1998;1393-1396.
5. Ma J.et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 91:1999;620-625.